
In the space of numerous weeks, COVID-19 has changed many industries and will continue to do so in methods we can just think of.
For years, robotics and automation have been a looming presence in a number of fields varying from shipping and fulfillment to construction websites and running rooms.
These modifications take time, however because COVID-19 will not be vanishing any time quickly, it seems likely that this age will transform a number of the robotics- and automation-curious into full-fledged converts. How various would this minute be if we were bolstered by a labor force that couldn’t send viruses or hire ill?
Following current studies exploring COVID-19’s impact on media, fintech start-ups and esports, together with an earlier expedition of robotics investments, we have actually asked the classification’s top VCs to discuss how the pandemic will impact their portfolio companies:
- Shahin Farshchi, Lux Capital
- Aaron Jacobson, NEA
- Kelly Chen, DCVC
- Cyril Ebersweiler and Duncan Turner, SOSV & HAX
- Eric Migicovsky, Y Combinator
- Helen Liang, FoundersX Ventures
Shahin Farshchi, Lux Capital
How has COVID-19 affected automation and the robotics investing landscape?
We just closed on a fresh $1 billion and are actively making brand-new financial investments in automation. COVID-19 exposed that our just-in-time manufacturing and logistics facilities can not respond to unanticipated modification. We expect the best practices of tech companies: quickly adopting brand-new tools and rapidly iterating on their products and procedures to become typical in the world of production and logistics. Engineers will be handed credit cards to try the latest tools, building on open source will be extensively accepted, and making bets on products from start-ups will become the standard in this market which has its roots in the industrial transformation.
COVID-19 has developed a duration of uncertainty relating to require, which will affect makers’ capability to purchase automation to meet that demand.
Comments
Post a Comment